Skip to main content

IQVIA statistics

  • IQV · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$265.12−2.21%Close 13 Nov 2026 · Market value $43.51B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

IQVIA is valued at $43.51B on its latest close. Its price is 31.2 times its earnings.

Market value$43.51B
Enterprise value$57.71B
Price / earnings31.21
Price / sales2.51
Price / book6.53
EV / EBITDA16.79
EV / sales3.33
Price / free cash flow20.93
Price / free cash flow, own 5-year average21.00
EV / EBIT25.87
EV / free cash flow27.61
Free cash flow yield4.8%

Share price

Latest close$265.12
Day's change−2.2%
52-week high$284.50
52-week low$154.50
From 52-week high−6.8%
Return · 1 month−0.7%
Return · 3 months+3.5%
Return · year to date+17.6%
Return · 1 year+20.0%
Beta · 1 year against the S&P 5000.68
50-day average$267.41
200-day average$211.03
RSI 1446.5
Average volume · 20 sessions1.5M

Margins and returns

For fiscal 2025, as filed.

Operating margin13.4%
Net margin8.3%
Free cash flow margin12.6%
Return on equity21.6%
Return on assets6.5%
Return on invested capital7.7%
Return on invested capital, 5-year average7.5%
Return on capital employed10.5%
Stock-based compensation / revenue1.5%

Financial position

At the end of fiscal 2025.

Cash and equivalents$1.98B
Total debt$16.04B
Net debt$13.90B
Current ratio0.75
Quick ratio0.31
Debt / equity2.47
Net debt / EBITDA4.18
Interest coverage2.99

Growth

Revenue, latest quarter on a year+8.0%
Revenue, twelve months on a year+8.8%
EPS, latest quarter on a year+8.8%
EPS, twelve months on a year+13.0%
Revenue, 5-year compound+7.5%
Revenue, 10-year compound+11.0%
Net income, 5-year compound+37.3%
Free cash flow, 5-year compound+8.8%
EPS, 5-year compound+40.5%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares174M
Shares outstanding, 5-year compound−2.3%
Net share repurchases$1.24B

Taxes

For fiscal 2025, as filed.

Income tax expense$252.0M
Effective tax rate15.8%

IQV in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.